With routine market-facing activities on pause, now’s the time to enhance your credibility in the market.
Medtech stakeholders demand evidentiary support of your clinical and economic value, and creating a compelling value story involves effectively proving that your technology outshines competitors with real world evidence – particularly in crowded sectors of the market (e.g. cardiac). One of the most effective ways of demonstrating this is through peer-reviewed publications.
An extensive track record can:
- Improve your credibility in the market surrounding your technology
- Attract new investors to your technology
- Help to enhance knowledge within bodies of research
- Contribute evidence to inform or update clinical guidelines
Ian online search of your technology provides little more than press releases and marketing pieces, you’re endangering your potential share of the market.
Even if your definitive studies are not completed, you can still start publishing to build your track record and establish credibility. Exploratory studies are valuable for more than just informing large scale, definitive studies – they are an opportunity for generating buzz in the marketplace surrounding your technology. Peer-reviewed, exploratory publications can attract a following around your technology.